Remsima

Switching study gives Celltrion biosim more ammo in fight for Remicade share
Switching study gives Celltrion biosim more ammo in fight for Remicade share
Fierce Pharma Marketing
Celltrion
biosimilars
Merck
Remicade
Remsima
Flag link:
FDA reviewers support Celltrion's biosimilar Remicade
FDA reviewers support Celltrion's biosimilar Remicade
Yahoo/Reuters
FDA
Celltrion
biosimilars
Remicade
arthritis
Remsima
JNJ
Pfizer
Flag link:
Competition to J&J's Remicade looms in U.S. as biosimilar conquers new markets
Competition to J&J's Remicade looms in U.S. as biosimilar conquers new markets
Fierce Biotech
JNJ
Remicade
biosimilars
FDA
Celltrion
Remsima
Flag link:
Most Popular News Headlines For Monday, August 11 2014
Most Popular News Headlines For Monday, August 11 2014
CP Wire
Celltrion
Remsima
Jannsen
Remicade
Invokamet
JNJ
Sanofi
Cologuard
MannKind
Afrezza
EXACT Sciences
Flag link:
Most popular news headlines for Monday, August 11 2014
Celltrion
Remsima
Jannsen
Remicade
Invokamet
JNJ
Sanofi
Cologuard
MannKind
Afrezza
EXACT Sciences
Flag link:
FDA Accepts First-Ever Biosimilar Application for Monoclonal Antibody
FDA Accepts First-Ever Biosimilar Application for Monoclonal Antibody
RAPS.org
Remsima
Remicade
monoclonal antibodies
FDA
Celltrion
biosimilars
Flag link:
Biogen's Biosimilars Vs. Amgen, Johnson & Johnson
Biogen's Biosimilars Vs. Amgen, Johnson & Johnson
Seeking Alpha
Amgen
Biogen Idec
biosimilars
JNJ
Samsung Bioepis
Celltrion
Hospira
Remsima
Inflectra
Flag link:
Biosimilar versions of Remicade given EU green light
Biosimilar versions of Remicade given EU green light
Reuters
Remicade
biosimilars
Europe
Celltrion
Remsima
Hospira
Inflectra
rheumatoid arthritis
Flag link: